Positive Top-line Results from the Phase III Breast Cancer Study PALOMA-2 for the CDK 4/6 Inhibitor Palbociclib

Janik Achim

首页> 外文期刊>Breast care >Positive Top-line Results from the Phase III Breast Cancer Study PALOMA-2 for the CDK 4/6 Inhibitor Palbociclib

【24h】

Positive Top-line Results from the Phase III Breast Cancer Study PALOMA-2 for the CDK 4/6 Inhibitor Palbociclib

机译：CDK 4/6抑制剂Palbociclib的III期乳腺癌研究PALOMA-2的阳性结果为阳性

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Breast care》 |2016年第3期|共1页
作者
Janik Achim;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿生殖器肿瘤;
关键词

相似文献

外文文献
中文文献
专利

1. Positive Top-line Results from the Phase III Breast Cancer Study PALOMA-2 for the CDK 4/6 Inhibitor Palbociclib [J] . Janik Achim Breast care . 2016,第3期

机译：CDK 4/6抑制剂Palbociclib的III期乳腺癌研究PALOMA-2的阳性结果为阳性
2. Palbociclib: a first-in-class CDK4/CDK6 inhibitor for the treatment of hormone-receptor positive advanced breast cancer [J] . Janice Lu Journal of Hematology and Oncology . 2015,第1期

机译：Palbociclib：一流的CDK4 / CDK6抑制剂，用于治疗激素受体阳性的晚期乳腺癌
3. Pfizer Presented Data from PALOMA-2 Phase 3 Study Demonstrating Clinical Benefit of IBRANCE~R (palbociclib) in Asian Women with ER+, HER2- Metastatic Breast Cancer [J] . Asia-Pacific Biotech News . 2017,第3期

机译：辉瑞提出了Paloma-2第3期的数据，证明了Ibrance〜R（Palbociclib）的亚洲女性患有ER +，Her2-转移性乳腺癌的临床益处
4. Stilbene analogues as inhibitors of breast cancer Stem cells through P-glycoprotein efflux; A 3D quantitative structure-activity relationship study (Inhibitory activity of stilbenes analogues on breast cancer stem cells) [C] . Anushree Tripathi, Krishna Misra 2016 International Conference on Bioinformatics and Systems Biology . 2016

机译：Stilbene类似物通过P-糖蛋白外排作为乳腺癌干细胞的抑制剂； 3D定量结构-活性关系研究（Stilbenes类似物对乳腺癌干细胞的抑制活性）
5. A phase Ib study of safety and pharmacokinetics of trastuzumab emtansine and pertuzumab in Japanese patients with HER2-positive metastatic breast cancer [D] . NOGUCHI, Emi 2019

机译：Ib期研究曲妥珠单抗氨丹宁和帕妥珠单抗在日本HER2阳性转移性乳腺癌患者中的安全性和药代动力学
6. Palbociclib Plus Letrozole as First-Line Therapy in Postmenopausal Asian Women With Metastatic Breast Cancer: Results From the Phase III Randomized PALOMA-2 Study [O] . Seock-Ah Im, Hirofumi Mukai, In Hae Park, 2019

机译：Palbociclib加来曲唑作为绝经后亚洲转移性乳腺癌妇女的一线治疗方法：III期随机PALOMA-2研究结果
7. Palbociclib: a first-in-class CDK4/CDK6 inhibitor for the treatment of hormone-receptor positive advanced breast cancer [O] . 2015

机译：Palbociclib：一流的CDK4 / CDK6抑制剂，用于治疗激素受体阳性的晚期乳腺癌

Positive Top-line Results from the Phase III Breast Cancer Study PALOMA-2 for the CDK 4/6 Inhibitor Palbociclib

著录项

引文网络

相似文献

相关主题

期刊订阅